Promises and problems of functional foods

Critical Reviews in Food Science and Nutrition

Volumn 44, Issue 5, 2004, Pages 369-377

  Katan, Martijn B ^a   De Roos, Nicole M ^b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Functional foods; Health claims; Nutraceuticals; Regulation; Supplements

Indexed keywords

FUNCTIONAL FOODS; HEALTH CLAIMS; NUTRACEUTICALS; REGULATION;

DRUG PRODUCTS; GENETIC ENGINEERING; HEALTH CARE; LAWS AND LEGISLATION; NUTRITION; TUMORS;

DAIRY PRODUCTS;

ARTICLE; EUROPE; HEALTH CARE POLICY; HEALTH FOOD; HUMAN; JAPAN; STANDARD; UNITED STATES;

EUROPE; HEALTH FOOD; HUMANS; JAPAN; NUTRITION POLICY; UNITED STATES;

NEOPLEA;

EID: 5444245662     PISSN: 10408398     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408690490509609     Document Type: Article

References (68)

1. Age-Related Eye Disease Study Research Group. 2001. A randomized, placebocontrolled, clinical trial of high-dose supplementation with vitamins C and E beta carotene and zinc for age-related macular degeneration and vision loss, AREDS Report no. 8. Arch Ophthalmol, 1417-1436.
2. Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. 1994. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New Engl. J. Med., 330:1029-1035.
3. Andrews, J.C., Netemeyer, R.G., and Burton, S. 1998. Consumer generalization of nutrient content claims in advertising. J. Marketing, 62:62-75.
4. Ang-Lee, M.K., Moss, J., and Yuan, C.S. 2001. Herbal medicines and perioperative care. JAMA, 286:208-216.
5. Anttolainen, M., Luoto, R., Uutela, A., Boice, J.D., Blot, W.J., and McLaughlin, J.K. 2001. Characteristics of users and non-users of plant stanol ester margarine in Finland - An approach to study functional foods. J. Am. Diet. Assoc., 101:1365-1368.
6. Asplund, K. 2002. Antioxidant vitamins in the prevention of cardiovascular disease: A systematic review. J. Intern. Med., 251:372-392.
7. Baily, R. 1999. Foods for Specified Health Use (FOSHU) as Functional Foods in Japan. Canadian Chemical News., May 18-19.
8. Beaubrun, G. and Gray, G.E. 2000. A review of herbal medicines for psychiatric disorders. Psychiatr. Serv., 51:1130-1134.
9. Belury, M.A. 2002. Dietary conjugated linoleic acid in health: Physiological effects and mechanisms of action. Annu. Rev. Nutr., 22:505-531.
10. Bucci, L.R. 2000. Selected herbals and human exercise performance. Am. J. Clin. Nutr., 72:624S-636S.
11. Centers for Disease Control and Prevention. 1993. Recommendations for use of folic acid to reduce number of spina bifida cases and other neural tube defects. JAMA, 269:1233-1238.
12. Center for Sciences in the Public Interest. 1999. Functional Foods: Public Health Boon or 21st Century Quackery? March. Washington.
13. Committee on Opportunities in the Nutrition and Food Sciences FaNBIoM. 1994. Opportunities in the Nutrition and Food Sciences: Research Challenges for the Next Generation of Investigators. Washington, DC: National Academy Press.
14. Consumer motivation shifts to shorter-term health concerns. 2000. Nutr. Business J., February 12-13.
15. Cummings, J.H. and Macfarlane, G.T. 2002. Gastrointestinal effects of prebiotics. Br. J. Nutr., 87:S145-S151.
16. De Roos, N.M. and Katan, M.B. 2000. Effects of priobiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: A review of papers published between 1988 and 1998. Am. J. Clin. Nutr., 71:405-411.
17. De Vries, J.H.M., Hollman, P.C.H., Van Amersfoort, II., Olthof, M.R., and Katan, M.B. 2001. Red wine is a poor source of bioavailable flavonols. J. Nutr., 131:745-748.
18. Duggan, C., Gannon, J., and Walker, W.A. 2002. Protective nutrients and functional foods for the gastrointestinal tract. Am. J. Clin. Nutr., 75:789-808.
19. Ernst, E. 2002. The risk - benefit profile of commonly used herbal therapies: Gingko, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann. Intern. Med., 136:42-53.
20. Gaster, B. and Holroyd, J. 2000. St. John's wort for depression: A systematic review. Arch. Intern. Med., 160:152-156.
21. Gibson, G.R. and Roberfroid, M.B. 1995. Dietary modulation of the human colonic microbiotia: Introducing the concept of prebiotics. J. Nutr., 125:1401-1412.
22. Giovannucci, E., Rimm, E.B., Wolk, A., Ascherio, A., Stampfer, M.J., and Colditz, G.A. 1998. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res., 58:442-447.
23. Gissi-Prevenzione Investigators. 1999. Dietary supplementation with n-3 poly-unsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet, 354:447-455.
24. Glazier, M.G. and Bowman, M.A. 2001. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch. Intern. Med., 161:1161-1172.
25. Hagenmeyer, M. 2000. How to market functional food without contravening European law. In Developing & Marketing Future Foods: The Challenge of Communication, pp. 21-23. Lähteenmäki, L., Poutanen, K., Bergqvist, P., eds. Helsinki, Finland: Technical Research Centre of Finland.
26. Haller, C.A. and Benowitz, N.L. 2000. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N. Engl. J. Med., 343:1833-1838.
27. Hathcock, J.N. 1997. Vitamins and minerals: Efficacy and safety. Am. J. Clin. Nutr., 66:427-437.
28. Havel, R.J. 1999. Dietary supplement or drug? The case of cholestin. Am. J. Clin. Nutr., 69:175-176.
29. Hayes, C. 2001. The effect of non-cariogenic sweeteners on the prevention of dental caries: A review of the evidence. J. Dent. Educ., 65(10): 1106-1109.
30. Health Council of the Netherlands: Committee on the Safety Assessment of Novel Foods. Phytosterols (2). Publication no 2001/04VNV. 2001. The Hague, Health Council of the Netherlands.
31. Heaney, R.P. 2000. Calcium, dairy products, and osteoporosis. J. Am. Coll. Nutr., 19:83S-99S.
32. Hollman, P.C.H., Feskens, E.J.M., and Katan, M.B. 1999. Tea Flavonols in Cardiovascular Disease and Cancer epidemiology. Proc. Soc. Exp. Biol. Med., 220:198-202.
33. Hu, F.B., Stampfer, M.J., Manson, J.E., Grodstein, F., Colditz, G.A., and Speizer, F.E. 2000. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N. Engl. J. Med., 343:530-537.
34. Isolauri, E., Arvola, T., Sutas, Y., Moilanen, E., and Salminen, S. 2000. Probiotics in the management of atopic eczema. Clin. Exp. Allergy., 30:1604-1610.
35. Isolauri, E., Kaila, M., Mykkänen, H., Ling, W.H., and Salminen, S. 1994. Oral bacteriotherapy for viral gastroenteritis. Digest. Dis. Sci., 39:2595-2600.
36. Joint Health Claims Initiative. 2004. Code of practice on health claims for foods. www.jhci.org.uk/code.pdf
37. Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., and Isolauri, E. 2001. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet., 357:1076-1079.
38. Katan, M.B., Grundy, S.M., Jones, P.J.H., Law, M.R., Miettinen, T., and Paoletti, R. 2003. Efficacy and safety of plant stanols and sterols in the control of blood cholesterol levels. Mayo. Clin. Proc., 78:965-978.
39. Kessler, D.A. 2000. Cancer and herbs. New Engl. J. Med., 342:1742-1743.
40. Kitts, D. and Hu, C. 2000. Efficacy and safety of ginseng. Public Health Nutr., 3:473-485.
41. Le Bars, P.L. and Kastelan, J. 2000. Efficacy and safety of a Ginkgo biloba extract. Public Health Nutr., 3:495-499.
42. Lichtenstein, A.H. 1998. Soy protein, isoflavones, and cardiovascular disease risk. J. Nutr., 128:1589-1592.
43. Linde, K., Ter Riet, G., Hondras, M., Vickers, A., Saller, R., and Melchart, D. 2001. Systematic reviews of complementary therapies - an annotated bibliography. Part 2: Herbal medicine. BMC Complement, Altern. Med., 1:5.
44. Marlett, J.A., McBurney, M.I., and Slavin, J.L. 2002. Position of the American Dietetic Association: Health implications of dietary fiber. J. Am. Diet. Assoc., 102:993-1000.
45. Marshall, I. 2000. Zinc for the common cold. Cochrane Database Syst. Rev., CD001364.
46. Melchart, D., Linde, K., Fischer, P., and Kaesmayr, J. 2000. Echinacea for preventing and treating the common cold. Cochrane. Database Syst. Rev., (2):CD000530.
47. Mukamal, K. J., Maclure, M., Muller, J. E., Sherwoord, J. B., and Mittleman, M. A. 2002. Tea consumption and mortality after acute myocardial infarction. Circulation, 105:2476-2481.
48. Nestle, M. 2002. Food politics: How the food industry influences nutrition and health. London, England: University of California Press, Ltd.
49. Netherlands Nutrition Centre. 2004. Code of Practice for assessing the scientific evidence for health benefits as stated in health claims on food and drink products. http://www.voedingscentrum.nl/content/documents/ Code_of_Practice_Health_Claims.pdf
50. Omenn, G.S., Goodman, G.E., Thornquist, M.D., Balmes, J., Cullen, M.R., and Glass, A. 1996. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New Engl. J. Med., 334:1150-1155.
51. Sacks, F.M. and Katan, M.B. 2002. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am. J. Med., 1133(9B):13S-24S.
52. Sacks, F.M., Svetkey, L.P., Vollmer, W.M., Appel, L.J., Bray, G.A., and Harsha, D. 2001. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N. Engl. J. Med., 344:3-10.
53. Schnyder, G., Flammer, Y., Rofifi, M., Pin, R., and Hess, O.M. 2002. Plasma homocysteine levels and late outcome after coronary angioplasty. J. Am. Coll. Cardiol., 40:1769-1776.
54. Schrezenmeir, J. and De Vrese, M. 2001. Probiotics, prebiotics and synbiotics - approaching a definition. Am. J. Clin. Nutr., 73:361S-364S.
55. Shelton, R.C., Keller, M.B., Gelenberg, A., Dunner, D.L., Hirschfeld, R., and Thase, M.E. 2001. Effectiveness of St John's wort in major depression: A randomized controlled trial. JAMA, 285:1978-1986.
56. Solomon, P.R., Adams, F., Silver, A., Zimmer, J., and DeVeaux, R. 2002. Ginkgo for memory enhancement: A randomized controlled trial. JAMA, 288:835-840.
57. Southern, R. 2000. Factors to consider when undertaking clinical trials for functional foods. In Functional foods II: Claims and evidence, pp. 3-7. Buttriss, J., Saltmarsh, M., eds. Cambridge (UK): Royal Society of Chemistry.
58. Swanson, C.A. 2002. Suggested guidelines for articles about botanical dietary supplements. Am. J. Clin. Nutr., 75:8-10.
59. Thomas, M.R., Litin, S.C., Osmon, D.R., Corr, A.P., Weaver, A.L., and Lohse, C.M. 2001. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: A randomized, placebo-controlled trial. Mayo. Clin. Proc., 76:883-889.
60. Thomson, C., Block, A.S., and Hasler, C.N. 1999. Position of the American Dietetic Association: Functional foods. J. Am. Diet. Assoc., 99:1278-1285.
61. Truswell, A.S. 1994. Review of dietary intervention studies: Effect on coronary events and on total mortality. Aust. N. Z. J. Med., 24:98-106.
62. Truswell, A.S. 2001. Levels and kinds of evidence for public-health nutrition. Lancet., 357:1061-1062.
63. Truswell, A.S. 2002. Cereal grains and coronary heart disease. Eur. J. Clin. Nutr., 56:1-14.
64. U.S. Food and Drug Administration. 2004. Interpretation of Significant Scientific Agreement in the Review of Health claims. http://www.cfsan.fda.gov/ ~dms/facssa.html.
65. United States General Accounting Office. 2000. Food Safety: Improvements needed in overseeing the safety of dietary supplements and "Functional foods." GAO/RCED-00-156. pp. 1-30.
66. United States General Accounting Office. 2001. Health products for seniors. Anti-aging products pose potential for physical and economic harm. GAO-01-1120.
67. van der Schouw, Y.T., de Kleijn, M.J., Peeters, P.H., and Grobbee, D.E. 2000. Phyto-oestrogens and cardiovascular disease risk. Nutr. Metab. Cardiovasc. Dis., 10:154-167.
68. Yusuf, S., Dagenais, G., Pogue, J., Bosch, J., and Sleight, P. 2000. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. New Engl. J. Med., 342:154-160.